Mereo BioPharma Group Plc (MREO)
0.27
+0.02
(+6.93%)
USD |
NASDAQ |
Aug 31, 16:00
0.27
0.00 (0.00%)
After-Hours: 16:19
Mereo BioPharma Group Free Cash Flow : -25.58M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -25.58M |
| March 31, 2026 | -27.29M |
| December 31, 2025 | -31.36M |
| September 30, 2025 | -33.02M |
| Date | Value |
|---|---|
| June 30, 2025 | -33.39M |
| March 31, 2025 | -33.54M |
| December 31, 2024 | -33.55M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Biodexa Pharmaceuticals Plc | -8.310M |
| NuCana Plc | -6.612M |
| BioNTech SE | 424.34M |
| Silence Therapeutics Plc | -41.79M |
| Autolus Therapeutics Plc | -240.12M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.048M |
| Cash from Investing (Quarterly) | -0.0004M |
| Free Cash Flow Per Share (Quarterly) | -0.0376 |
| Free Cash Flow to Equity (Quarterly) | -7.079M |
| Free Cash Flow to Firm (Quarterly) | -6.049M |
| Free Cash Flow Yield | -59.19% |